How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

GLP-1 Receptor Agonists Added to Statin Therapy and Cardiovascular Outcomes in ASCVD A Propensity Score-Matched Cohort Study

calendar_today November 6, 2026 person Tah, S., Cheshire, M. domain medrxiv

Objective: To evaluate whether GLP-1 RA use added to statins is associated with lower all-cause mortality, myocardial infarction (MI), and ischemic stroke versus statin monotherapy in ASCVD patients with body mass index (BMI) 30 kg/m2. Approach and Results:Using the TriNetX Research Network (108 U.S. healthcare organizations), we identified ASCVD patients with BMI 30 kg/m2 on statins initiating a GLP-1 RA (n=166,278) versus statin-only controls (n=920,176).

open_in_new Read original post